Saeed, A., Hildebrand, H., Park, R., Al-Jumayli, M., Abbasi, S., Melancon, T., . . . Sun, W. (2020). Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study. J Clin Med.
Citação norma ChicagoSaeed, Anwaar, et al. "Immune Checkpoint Inhibitors Versus VEGF Targeted Therapy As Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study." J Clin Med 2020.
Citação norma MLASaeed, Anwaar, et al. "Immune Checkpoint Inhibitors Versus VEGF Targeted Therapy As Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study." J Clin Med 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.